Verve Therapeutics
VERV
#6702
Rank
NZ$0.86 B
Marketcap
$9.70
Share price
5.67%
Change (1 day)
-12.45%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -NZ$0.39 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are NZ$32.33 Million. a decrease over its 2023 earnings that were of -NZ$0.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.39 Billion2.48%
2023 -NZ$0.38 Billion34.67%
2022 -NZ$0.28 Billion90.3%
2021 -NZ$0.15 Billion114.31%
2020 -NZ$68.22 Million